Class II
Terminated
Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03) Mfd By: Hospira, Inc., Lake Fo…
Why: Presence of Particulate Matter: Silicone oil
- Company
- HOSPIRA INC, LAKE FOREST
LAKE FOREST, IL, United States - Reported
- Aug 16, 2017
- Recall started
- Jul 26, 2017
- Ended
- May 11, 2018
- Where sold
- Nationwide in the USA
- Amount
- 56,340 vials
- Full product description
- Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03) Mfd By: Hospira, Inc., Lake Forest, IL 60045 USA, Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA.
- Lots / codes affected
- Lot #: 560103F, Exp. 01AUG2017
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.